GRANADILLO PEDRO P
Insider CIK 1217544 · DNDN Director · RCKT Director · HAE Director · NPSP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2025-06-18 | 2025-07-18 | 24,734 | — | $0 | 54,734 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2025-06-18 | 2025-07-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2024-06-13 | 2024-06-20 | 23,944 | — | $0 | 23,944 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2024-06-13 | 2024-06-20 | 4,655 | $15.04 | $70.0K | 4,655 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2023-06-22 | 2023-06-26 | 25,850 | — | $0 | 25,850 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2023-06-22 | 2023-06-26 | 5,026 | $13.93 | $70.0K | 5,026 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2022-06-13 | 2022-06-15 | 47,745 | — | $0 | 47,745 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2022-06-13 | 2022-06-15 | 10,283 | $6.80 | $69.9K | 10,283 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2021-06-14 | 2021-06-16 | 2,379 | $29.42 | $70.0K | 2,379 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2021-06-14 | 2021-06-16 | 12,236 | — | $0 | 12,236 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2020-06-16 | 2020-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2019-01-28 | 2019-01-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2018-11-08 | 2018-11-09 | 12,322 | $114.50 | $1.41M | 15,335 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2018-09-17 | 2018-09-19 | 10,353 | — | $0 | 0 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2018-09-17 | 2018-09-19 | 6,573 | — | $0 | 0 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2018-09-17 | 2018-09-19 | 8,196 | — | $0 | 0 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2018-09-17 | 2018-09-19 | 11,812 | $113.16 | $1.34M | 28,288 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2018-09-17 | 2018-09-19 | 13,183 | $111.33 | $1.47M | 40,100 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2018-09-17 | 2018-09-19 | 3,696 | $110.11 | $407.0K | 53,283 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2018-09-17 | 2018-09-19 | 631 | $114.16 | $72.0K | 27,657 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2018-09-17 | 2018-09-19 | 1,502 | $108.92 | $163.6K | 56,979 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2018-09-17 | 2018-09-19 | 8,196 | $36.37 | $298.1K | 41,555 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2018-09-17 | 2018-09-19 | 6,573 | $45.45 | $298.7K | 48,128 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2018-09-17 | 2018-09-19 | 10,353 | $35.50 | $367.5K | 58,481 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2018-07-26 | 2018-07-30 | 1,696 | — | $0 | 33,359 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2018-03-29 | 2018-04-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2017-12-01 | 2017-12-04 | 7,118 | — | $0 | 0 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 200 | $57.09 | $11.4K | 32,421 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 100 | $57.07 | $5.7K | 32,821 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 760 | $57.07 | $43.4K | 32,921 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 200 | $57.06 | $11.4K | 33,681 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 4,100 | $57.06 | $233.9K | 33,881 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 9 | $57.05 | $513 | 37,981 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 100 | $57.03 | $5.7K | 37,990 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 91 | $57.02 | $5.2K | 38,090 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 100 | $57.02 | $5.7K | 38,181 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 100 | $57.01 | $5.7K | 38,281 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 100 | $57.01 | $5.7K | 38,381 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 300 | $57.00 | $17.1K | 38,481 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2017-12-01 | 2017-12-04 | 7,118 | $34.41 | $244.9K | 38,781 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 100 | $57.13 | $5.7K | 32,281 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 100 | $57.13 | $5.7K | 32,181 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 100 | $57.14 | $5.7K | 32,081 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 100 | $57.15 | $5.7K | 31,981 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 200 | $57.17 | $11.4K | 31,781 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 18 | $57.18 | $1.0K | 31,763 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 100 | $57.23 | $5.7K | 31,663 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 200 | $57.08 | $11.4K | 32,621 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2017-12-01 | 2017-12-04 | 40 | $57.10 | $2.3K | 32,381 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2017-07-27 | 2017-07-31 | 4,329 | $39.27 | $170.0K | 31,663 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2015-07-21 | 2015-07-23 | 4,337 | — | $0 | 21,632 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 10,459 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 36,000 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 3,816 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | U Tender | 2015-02-21 | 2015-02-24 | 30,413 | $46.00 | $1.40M | 0 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2015-02-18 | 2015-02-19 | 11,328 | $43.45 | $492.2K | 0 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2015-02-18 | 2015-02-19 | 11,328 | $29.23 | $331.1K | 28,623 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2015-02-18 | 2015-02-19 | 11,328 | $43.45 | $492.2K | 17,295 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-02-12 | 2015-02-20 | 3,816 | — | $0 | 3,816 | SEC↗ |
| HAE HAEMONETICS CORP | A Award deriv | 2014-07-23 | 2014-07-25 | 10,353 | — | $0 | 10,353 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2014-07-23 | 2014-07-25 | 2,394 | — | $0 | 17,295 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2014-07-07 | 2014-07-08 | 1,837 | $35.90 | $65.9K | 0 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2014-07-07 | 2014-07-08 | 4,000 | $36.01 | $144.0K | 0 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2014-07-07 | 2014-07-08 | 1,837 | $35.90 | $65.9K | 14,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2014-07-07 | 2014-07-08 | 4,000 | $14.95 | $59.8K | 18,901 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2014-07-07 | 2014-07-08 | 4,000 | $36.01 | $144.0K | 14,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2014-07-07 | 2014-07-08 | 1,837 | $24.96 | $45.9K | 16,738 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2014-06-06 | 2014-06-10 | 4,000 | $34.69 | $138.8K | 4,000 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2014-06-06 | 2014-06-10 | 1,837 | $39.70 | $72.9K | 1,837 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2014-06-06 | 2014-06-10 | 4,000 | $34.69 | $138.8K | 14,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2014-06-06 | 2014-06-10 | 1,837 | $24.96 | $45.9K | 16,738 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2014-06-06 | 2014-06-10 | 1,837 | $34.70 | $63.7K | 14,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2014-06-06 | 2014-06-10 | 4,000 | $14.95 | $59.8K | 18,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2014-05-07 | 2014-05-08 | 1,837 | $31.14 | $57.2K | 3,674 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2014-05-07 | 2014-05-08 | 4,000 | $31.14 | $124.6K | 8,000 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2014-05-07 | 2014-05-08 | 1,837 | $24.96 | $45.9K | 16,738 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2014-05-07 | 2014-05-08 | 1,837 | $31.14 | $57.2K | 14,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2014-05-07 | 2014-05-08 | 4,000 | $14.95 | $59.8K | 18,901 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2014-05-07 | 2014-05-08 | 4,000 | $31.14 | $124.6K | 14,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2014-04-07 | 2014-04-09 | 4,000 | $31.98 | $127.9K | 12,000 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2014-04-07 | 2014-04-09 | 1,837 | $31.98 | $58.7K | 5,511 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2014-04-07 | 2014-04-09 | 1,837 | $24.96 | $45.9K | 16,738 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2014-04-07 | 2014-04-09 | 1,837 | $31.98 | $58.7K | 14,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2014-04-07 | 2014-04-09 | 4,000 | $14.95 | $59.8K | 18,901 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2014-04-07 | 2014-04-09 | 4,000 | $31.98 | $127.9K | 14,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2014-03-10 | 2014-03-12 | 1,836 | $36.70 | $67.4K | 7,348 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2014-03-10 | 2014-03-12 | 4,000 | $36.70 | $146.8K | 16,000 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2014-03-10 | 2014-03-12 | 4,000 | $36.70 | $146.8K | 14,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2014-03-10 | 2014-03-12 | 4,000 | $14.95 | $59.8K | 18,901 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2014-03-10 | 2014-03-12 | 1,836 | $36.70 | $67.4K | 14,901 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2014-03-10 | 2014-03-12 | 1,836 | $24.96 | $45.8K | 16,737 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-02-13 | 2014-02-18 | 15,188 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-02-13 | 2014-02-18 | 15,188 | — | $0 | 30,413 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-18 | 4,572 | — | $0 | 4,572 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2014-01-03 | 2014-01-07 | 25,000 | — | $0 | 87,251 | SEC↗ |
| HAE HAEMONETICS CORP | A Award deriv | 2013-07-24 | 2013-07-26 | 6,573 | — | $0 | 6,573 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2013-07-24 | 2013-07-26 | 1,649 | — | $0 | 14,901 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-02-13 | 2013-02-15 | 15,188 | — | $0 | 15,188 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2013-02-07 | 2013-02-11 | 15,225 | — | $0 | 15,225 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2013-01-03 | 2013-01-07 | 25,000 | — | $0 | 62,251 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2012-11-12 | 2012-11-14 | 6,000 | — | $0 | 0 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2012-11-12 | 2012-11-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2012-11-12 | 2012-11-14 | 6,000 | $80.40 | $482.4K | 6,626 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2012-11-12 | 2012-11-14 | 6,000 | $52.76 | $316.6K | 12,626 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2012-11-12 | 2012-11-14 | 10,000 | $80.40 | $804.0K | 6,626 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2012-11-12 | 2012-11-14 | 10,000 | $29.90 | $299.0K | 16,626 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise deriv | 2012-08-13 | 2012-08-15 | 6,000 | — | $0 | 0 | SEC↗ |
| HAE HAEMONETICS CORP | M Exercise | 2012-08-13 | 2012-08-15 | 6,000 | $44.74 | $268.4K | 12,626 | SEC↗ |
| HAE HAEMONETICS CORP | S Sale | 2012-08-13 | 2012-08-15 | 6,000 | $70.05 | $420.3K | 6,626 | SEC↗ |
| HAE HAEMONETICS CORP | A Award deriv | 2012-07-27 | 2012-07-31 | 4,098 | — | $0 | 4,098 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2012-07-27 | 2012-07-31 | 1,031 | $0.01 | $10 | 6,626 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award | 2012-02-07 | 2012-02-09 | 15,225 | — | $0 | 15,225 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-01-17 | 2012-01-19 | 2,278 | — | $0 | 10,459 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2012-01-03 | 2012-01-05 | 25,000 | — | $0 | 37,251 | SEC↗ |